Biotage AB (publ)

BATS-CHIXE:BIOTS Stock Report

Market Cap: SEK 12.1b

Biotage Future Growth

Future criteria checks 3/6

Biotage is forecast to grow earnings and revenue by 19.5% and 12.1% per annum respectively. EPS is expected to grow by 19.6% per annum. Return on equity is forecast to be 11.1% in 3 years.

Key information

19.5%

Earnings growth rate

19.6%

EPS growth rate

Life Sciences earnings growth19.6%
Revenue growth rate12.1%
Future return on equity11.1%
Analyst coverage

Low

Last updated22 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:BIOTS - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,7574755386693
12/31/20252,4573553144773
12/31/20242,1562552653933
9/30/20242,117257243406N/A
6/30/20242,077251261399N/A
3/31/20241,981236268381N/A
12/31/20231,862246193284N/A
9/30/20231,603189148229N/A
6/30/20231,554216147223N/A
3/31/20231,541240220295N/A
12/31/20221,566268271341N/A
9/30/20221,524240285346N/A
6/30/20221,428228285338N/A
3/31/20221,337216290342N/A
12/31/20211,232205297353N/A
9/30/20211,188203273336N/A
6/30/20211,145187256321N/A
3/31/20211,096174222286N/A
12/31/20201,092175218279N/A
9/30/20201,083149213268N/A
6/30/20201,103179221274N/A
3/31/20201,131201211260N/A
12/31/20191,101187166212N/A
9/30/20191,047196145187N/A
6/30/2019997173112158N/A
3/31/201995117094139N/A
12/31/2018911168108155N/A
9/30/2018865175120170N/A
6/30/2018811162N/A149N/A
3/31/2018771148N/A168N/A
12/31/2017748139N/A169N/A
9/30/2017738122N/A145N/A
6/30/2017728118N/A145N/A
3/31/2017694105N/A131N/A
12/31/201666893N/A139N/A
9/30/201665796N/A130N/A
6/30/201664087N/A133N/A
3/31/201662578N/A133N/A
12/31/201561173N/A120N/A
9/30/201558083N/A116N/A
6/30/201554975N/A98N/A
3/31/201552175N/A94N/A
12/31/201449065N/A81N/A
9/30/201447453N/A72N/A
6/30/201445949N/A70N/A
3/31/201445546N/A52N/A
12/31/201344541N/A57N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BIOTS's forecast earnings growth (19.5% per year) is above the savings rate (2.1%).

Earnings vs Market: BIOTS's earnings (19.5% per year) are forecast to grow faster than the UK market (14.6% per year).

High Growth Earnings: BIOTS's earnings are forecast to grow, but not significantly.

Revenue vs Market: BIOTS's revenue (12.1% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: BIOTS's revenue (12.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BIOTS's Return on Equity is forecast to be low in 3 years time (11.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y